Big Pharma charging Americans average 779% more than Turkey for their products – Politics and Other Controversies -Democrats, Republicans, Libertarians, Conservatives, Liberals, Third Parties, Left-Wing, Right-Wing, Congress, President – Page 3 – City-Dat
Quote: : I'm actually surprised that drug price-indexing hasn't gotten bi-partisanship support, especially ever since Trump transformed the GOP to [...]
Poll: A Majority of Americans Favor Allowing the Federal Government to Negotiate Prices on Prescription Drugs
There’s been no shortage of coverage on the Democrats’ budget reconciliation package, which includes a proposal that would allow the [...]
Drug Corporations Kick Lobbying into High Gear to Stop Medicare Drug Price Negotiation
October 12, 2021 Drug Corporations Kick Lobbying into High Gear to Stop Medicare Drug Price Negotiation Millions of dollars in [...]
FDA Acting Commissioner of Food and Drugs Seeks Collaboration Between FDA and USPTO to Address Pharmaceutical Patent-Related Matters Affecting Competition
On September 10, 2021, Janet Woodcock, Acting Commissioner of the U.S. Food and Drug Administration (FDA), sent a letter to [...]
Medicare should be able to negoitiate Drug Prices
PhRMA launches 7-figure ad campaign against Democrats' drug pricing measures https://thehill.com/policy/healthcare/572397-phrma-launches-7-figure-ad-campaign-against-democrats-drug-pricing-measures The Pharmaceutical Research and Manufacturers of America (PhRMA) announced [...]
Rent Seeking: Drug Pricing and the Pharmaceutical Industry
I recently came across this article entitled “Centrist Democrats scramble House drug pricing effort” on how three Democrats in the [...]
Kyrsten Sinema Is Doing Big Pharma’s Bidding
Kyrsten Sinema Is Doing Big Pharma’s Bidding Kyrsten Sinema could block Democrats’ drug pricing negotiation plan — which may be [...]
Big Pharma’s Reward
Pharmaceutical interests are donating big money to Kyrsten Sinema, who could block Democrats’ drug pricing negotiation plan. AP Photo/Rick Scuteri [...]
The Health Design Podcast Interviews xCures CEO
In a recent installment of the Health Design Podcast, Moyez Jiwa interviewed xCures CEO Mika Newton. Newton’s many previous roles [...]
FDA Directors Discuss EUAs, Transparency, and COVID-19
In a recent meeting, Food and Drug Administration directors discussed how emergency use authorizations (EUAs) affected the response to the [...]
Putting a Price on Your Life
Democrats in Congress are working furiously to rewrite their partisan spending bill that would transform America into a European social [...]
Register for Upcoming Webinar on RWD in Decentralized Clinical Trials
A webinar highlighting the benefits of decentralized clinical trials that incorporate real world data (RWD) will take place on November [...]
Xavier Becerra Could Lower Drug Prices — So Why Isn’t He?
Xavier Becerra Could Lower Drug Prices — So Why Isn’t He? Calls are growing for President Joe Biden’s Health and [...]
Dispensing Doctors: Should Physicians Sell Drugs to Patients?
Visual: Undark; Base images via Getty Allowing doctors to also dispense drugs, some say, is cheaper and more convenient for [...]
Biotechnology And Pharmaceutical Services Outsourcing Market Outlook 2021: Big Things are Happening
Biotechnology And Pharmaceutical Services Outsourcing Market Outlook 2021: Big Things are Happening Latest published market study on Worldwide Biotechnology And [...]
Building a Patient-Centered Cancer Center From the Ground Up
For generations, people in New Jersey who received a diagnosis of cancer spoke of “going into the city” for treatment. [...]
Why Did Medicare Squander $600 Million on Efficacy-Free Cancer Drugs?
According to a new JAMA report, Medicare spent almost $600 million in three years on drugs used in oncology treatments. [...]
AUM Biosciences announces closing of USD $27Million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies
[AUM Biosciences announces closing of USD $27Million in a “Series A” Round of funding to advance its clinical stage pipeline [...]
Understanding the HCP: Patient-Level Data Proves Valuable
\n\nKey to the success of any pharmaceutical product is a deep understanding of healthcare professionals (HCPs): Who treats the indicated [...]
Opinion | Drug Companies Say We Can Have Innovation or Lower Prices. That’s a False Choice. – Yahoo News
inovation-business.blogspot.com America is the undisputed global leader in drug research and development, and pharmaceutical companies warn that imposing controls on [...]
Everbridge Wins 2021 Stratus Award for Its Industry-Leading Healthcare Solution Enabling Hospitals and Health Systems to Improve Secure Clinical Collaboration
BURLINGTON, Mass.--(BUSINESS WIRE)--Oct 13, 2021-- Everbridge , Inc. (NASDAQ: EVBG), the global leader in critical event management ( CEM ), [...]
ISPOR Issues Call for Nominations for 2022 President-Elect
The International Society for Pharmacoeconomics and Outcomes (ISPOR) is taking nominations for the role of President-Elect. The position will begin on [...]
Pepper Bio Emerges from Stealth with ‘Waze for Drug Discovery’ Technology
We founded Pepper Bio in order to significantly improve the volume, quality, and accuracy of the data analysis used to [...]
Emerging Trends in Healthcare Distribution Market 2021 and Global Foreseen Till 2028 | Analysis by Top Key Vendors – McKesson, Cardinal Health, Medline, Dakota Drug
Overview of Global Healthcare Distribution Market: Research analysts accomplish smart, resourceful and engaging surveys while creating Healthcare Distribution Market report [...]
Part 2 of AmerisourceBergen Podcast on Insulin Biosimilars Now Available
Part two of AmerisourceBergen’s podcast series on insulin biosimilars is now available. This episode features guidance for pharmacies awaiting updated [...]
